Postoperative treatment with octreotide in patients with gastroesophageal cancer: An open-label phase 2 study
Summary: Background & Aims: Dietary peptides are hypothesized to contribute to persistent weight loss following gastrectomy or esophagectomy in cancer patients. Previous studies have suggested that this effect might be partially mitigated by Octreotide. This study aimed to evaluate the safe...
Saved in:
Main Authors: | Anders Holmén, Maria Lampi, Ioannis Rouvelas, Berit Sunde, Thorhallur Agustsson, Greger Lindberg, Fredrik Klevebro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-10-01
|
Series: | Clinical Nutrition Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667268525000580 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
by: L. Yu. Morgunov
Published: (2015-06-01) -
Peculiarities of acute myocardial infarction course and distribution of the somatostatin receptor analogue 99mTc-octreotide in the heart
by: V. V. Ryabov, et al.
Published: (2024-03-01) -
Development of a method for preparing octreotide derivative for diagnosis of neuroendocrine tumors
by: M. S. Larkina, et al.
Published: (2019-10-01) -
Pharmacoeconomic analysis of lanreotide and prolonged-release octreotide in first- and second-line therapy of acromegaly
by: I. S. Krysanov, et al.
Published: (2025-05-01) -
Current Role and Potential of Oesophogeal and Gastric Fluoroscopy in the Choice of Surgical Treatment for Achalasia of Cardia
by: A. N. Anipchenko, et al.
Published: (2022-08-01)